Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese

Pathology International

Volumn 47, Issue 1, 1997, Pages 38-53

  Nakamura, Shigeo ^a   Katoh, Eriko ^a   Koshikawa, Takashi ^a   Yatabe, Yasushi ^a   Nagasaka, Tetsuro ^b   Ishida, Hiroji ^a   Tokoro, Yoshiro ^a   Koike, Koichi ^a   Kagami, Yoshitoyo ^a   Ogura, Michinori ^a   Kojima, Masaru ^c   Nara, Yoshiharu ^d   Mizoguchi, Yoshikazu ^e   Hara, Kazuo ^f   Kurita, Soji ^a   Seto, Masao ^a   Suchi, Taizan ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c ASHIKAGA RED CROSS HOSPITAL   (Japan)

^d Yokkaichi City Hospital   (Japan)

^e FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Epstein Barr virus; Japanese; nasal T natural killer cell lymphoma

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PROCARBAZINE; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOMA; MALE; MOLECULAR CLONING; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE RECEPTOR GENE;

EID: 8044233040     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04433.x     Document Type: Article

References (97)

1. Ishii Y, Yamanaka N, Ogawa K et al. Nasal T-cell lymphoma as a type of so-called 'lethal midline granuloma'. Cancer 1982; 50: 2336-2344.
2. Wilder WH, Harner SG, Banks PM. Lymphoma of the nose and paranasal sinuses. Arch. Otolaryngol. 1983; 109: 310-312.
3. Frierson HF, Mills SE, Innes DJ. Non-Hodgkin's lymphomas of the sinonasal region: Histologic subtypes and their clinicopathologic features. Am. J. Clin. Pathol. 1984; 81: 721-727.
4. Yamanaka N, Harabuchi Y, Sambe S et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Cancer 1985; 56: 768-776.
5. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am. J. Surg. Pathol. 1987; 11: 418-429.
6. Chott A, Rappersberger K, Schlossaret W, Radaszkiewicz T. Peripheral T-cell lymphoma presenting primarily as lethal midline granuloma. Hum. Pathol. 1988; 19: 1093-1101.
7. Aozasa K, Ohsawa M, Tajima K et al. Nationwide study of lethal mid-line granuloma in Japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int. J. Cancer 1989; 44: 63-66.
8. Fellbaum C, Hansmann ML, Lennert K. Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchows Arch. A. Pathol. Anat. Histopathol. 1989; 414: 399-405.
9. Frierson HF, Innes DJ Jr, Mills SE, Wick MR. Immunophenotypic analysis of sinonasal non-Hodgkin's lymphomas. Hum. Pathol. 1989; 20: 636-642.
10. Harabuchi Y, Yamanaka N, Kataura A et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1900; 335: 128-130.
11. Ho FCS, Choy D, Loke SL et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum. Pathol. 1990; 21: 1041-1050.
12. Liang R, Todd D, Chan TK et al. Nasal lymphoma: A retrospective study of 60 cases. Cancer 1990; 66: 2202-2209.
13. Park YN, Yang WL, Lee KG et al. Histopathological and immunohistochemical studies of polymorphic reticulosis. Yonsei Med. J. 1990; 31: 212-218.
14. Shima N, Kobashi Y, Tsutsui K et al. Extranodal non-Hodgkin's lymphoma of the head and neck: A clinicopathologic study in the Kyoto-Nara area of Japan. Cancer 1990; 66: 1190-1197.
15. Campo E, Cardesa A, Alos L et al. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses: An immunohistochemical study. Am. J. Clin. Pathol. 1991; 96: 184-190.
16. Ferry JA, Sklar J, Zukerberg LR, Harris NL. Nasal lymphoma: A clinicopathologic study with immunophenotypic and genotypic analysis. Am. J. Surg. Pathol. 1991; 15: 268-279.
17. Su IJ, Hsieh HC, Lin KH et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood 1991; 77: 799-808.
18. Kojima M, Hosomura Y, Kurabayashi Y et al. Malignant lymphomas of the nasal cavity and paranasal sinuses: A clinicopathologic and immunohistochemical study. Acta Pathol. Jpn. 1992; 42: 333-338.
19. Ye YL, Zhou MH, Lu XY, Dai YR, Wu WX. Nasopharyngeal and nasal malignant lymphoma: A clinicopathologic study of 54 cases. Histopathology 1992; 20: 511-516.
20. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru: High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am. J. Surg. Pathol. 1993; 17: 329-399.
21. Kanavaros P, Lescs MC, Briere J et al. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688-2695.
22. Yamaguchi M, Ohno T, Oka K et al. Discordant reaction of Leu4 and rabbit anti-human CD3 epsilon in sinonasal T-cell lymphoma. Int. J. Hematol. 1993; 59: 25-30.
23. Suzumiya J, Takeshita M, Kimura M et al. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 1994; 83: 2255-2260.
24. Van Gorp J, Weiping L, Jacobse K et al. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. J. Pathol. 1994; 173: 81-87.
25. Abbondanzo SL, Wenig BM. Non-Hodgkin's lymphoma of the sinonasal tract. Cancer 1995; 75: 1281-1291.
26. Jaffe ES. Nasal and nasal-type T/NK cell lymphoma: A unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 1995; 27: 581-583.
27. Van Gorp J, De Bruin PC, Sie-Go DMDS et al. Nasal T-cell lymphoma: A clinicopathological and immunophenotypic analysis of 13 cases. Histopathology 1995; 27: 139-148.
28. Jaffe ES, Chang JKC, Su IJ et al. Report of the workshop on nasal and related extranodal angiocentric T/NK-cell lymphomas: Definitions, differential diagnosis, and epidemiology. Am. J. Surg. Pathol. 1996; 20: 103-111.
29. Nonomura A, Matsubara F, Nakamura Y et al. T cell lymphoma presenting clinical and morphological features resembling polymorphic reticulosis and lymphomatoid granulomatosis. Acta Pathol. Jpn. 1983; 33: 1289-1301.
30. Jaffe ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest. 1984; 2: 413-426.
31. Jaffe E. Post-thymic lymphoid neoplasia. In: Jaffe ES, ed. Surgical Pathology of the Lymph Nodes and Related Organs. WB Saunders, Philadelphia, 1985; 218-248.
32. Yamanaka N, Kataura A, Sambe S et al. Midfacial T-cell lymphoma: Characterization by monoclonal antibodies. Ann. Otol. Rhinol. Laryngol. 1985; 94: 207-211.
33. Lippman SM, Grogan TM, Spier CM et al. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer 1987; 59: 936-939.
34. Lipford EG, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1988; 72: 1674-1681.
35. NakashimaT, Inamitsu M, Uemura T et al, Immunopathology of polymorphic reticulosis of the larynx. J. Laryngol. Otol. 1989; 103: 955-960.
36. Ratech H, Burke JS, Blayney DW, Shiebani K, Rappaport H. Clinicopathologic study of malignant lymphomas of the nose, paranasal sinuses, and hard plate, including cases of lethal midline granuloma. Cancer 1989; 64: 2525-2531.
37. Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: A molecular analysis of eight cases. Hum. Pathol. 1991; 22: 1150-1157.
38. Medeiros LJ, Jaffe ES, Chen YY et al. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am. J. Surg. Pathol. 1992; 16: 439-447.
39. Peiper SC. Angiocentric lymphoproliferative disorders of the respiratory system: Incrimination of Epstein-Barr virus in pathogenesis. Blood 1993; 82: 687-690.
40. Strickler JG, Meneses MF, Habermann TM et al. Polymorphic reticulosis: A reappraisal. Hum. Pathol. 1994; 25: 659-665.
41. + phenotype. Cancer 1995; 75: 894-901.
42. Furukawa M, Sakashita H, Kimura Y et al. Association of Epstein-Barr virus with polymorphic reticulosis. Eur. Arch. Otorhinolaryngol. 1990; 247: 261-263.
43. Ho FCS, Srivastava G, Loke SI et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol. Oncol. 1990; 8: 271-281.
44. Weiss LM, Gaffey MJ, Chen YY, Frierson HF. Frequency of Epstein-Barr viral DNA in 'Western' sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am. J. Surg. Pathol. 1992; 16: 156-162.
45. Su IJ, Hsieh HC. Clinicopathologic spectrum of Epstein-Barr virus-associated T-cell malignancies. Leuk. Lymphoma 1992; 7: 47-53.
46. Borisch B, Hennig I, Laeng H. Waelti ER, Kraft R, Laissue J. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993; 82: 858-864.
47. Chan JKC, Yip TTC, Tsang WYW et al. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am. J. Surg. Pathol. 1994; 18: 938-946.
48. De Bruin P, Jiwa M, Oudejans JJ et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: Differences in relation to site. Blood 1994; 83: 1612-1618.
49. Zhou XG, Hamilton-Dutoit SJ, Yan QH, Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 1994; 24: 115-122.
50. Ng CS, Chan JKC, Lo STH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum. Pathol. 1987; 18: 1257-1262.
51. Ng CS, Chan JKC, Hui PK, Chan WC, Lo STH. Application of a T-cell receptor antibody beta F1 for immunophenotypic analysis of malignant lymphomas. Am. J. Pathol. 1988; 132: 365-371.
52. Chubaci A, Imai H, Nishimura S, Saito M, Miura AB. Nasal T-cell lymphoma associated with hemophagocytic syndrome: Immunohistochemical and genotypic studies. Arch. Pathol. Lab. Med. 1992; 116: 1209-1212.
53. Chan JKC, Tsang WYW, Ng CS, Pau MY. Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. Hum. Pathol. 1995; 26: 1139-1143.
54. Yamaguchi M, Kita K, Miwa H et al. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 1995; 76: 2351-2356.
55. Harabuchi Y, Imai S, Wakashima J et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: Clinicopathologic, phenotypic, and genotypic studies. Cancer 1996; 77: 2137-2149.
56. Chiang AKS, Srivastava G, Lau PWF, Ho FCS. Differences in T-cell receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: Implications on cellular origin. Hum. Pathol. 1996; 27: 701-707.
57. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
58. Suchi T, Lennert K, Tu LY et al. Histopathology of peripheral T cell lymphoma: A proposal for their classification. J. Clin. Pathol. 1987; 40: 995-1015.
59. Nakamura S, Suchi T. A Clinicopathologic study of node-based, low-grade, peripheral T-cell lymphoma. Angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer 1991; 67: 2565-2578.
60. Nakamura S, Takagi N, Kojima M et al. Clinicopathologic study of large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among the Japanese. Cancer 1991; 68: 118-129.
61. Takagi N, Nakamura S, Ueda R et al. Phenotypic and genotypic study of node-based, low-grade, peripheral T-cell lymphoma: Angioimmunoblastic lymphoma (AILD), T-zone lymphoma and lymphoepithelioid lymphoma. Cancer 1992; 69: 2571-2582.
62. Nakamura S, Suchi T, Koshikawa T et al. Clinicopathologic study of 212 cases of peripheral T-cell lymphoma among the Japanese. Cancer 1993; 72: 1762-1772.
63. Nakamura S, Koshikawa T, Koike K et al. Phenotypic analysis of peripheral T cell lymphoma among the Japanese. Acta Pathol. Jpn. 1993; 43: 396-412.
64. Nakamura S, Suchi T, Koshikawa T et al. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am. J. Surg. Pathol. 1995; 19: 284-296.
65. Lennert K, Feller AC, eds. Histopathology of Non-Hodgkin's Lymphomas. Springer, Berlin, 1992.
66. Nakamura S, Suchi T, Koshikawa T et al. Aggressive rectal lymphoma of large granular lymphocytes with the histologic feature of an angiocentric growth pattern. Cancer 1993; 71: 249-256.
67. Kobashi Y, Nakamura S, Sasajima Y et al. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Histopathology 1996; 28: 111-120.
68. Delellis RA, Sternberger LA, Mann RB, Banks PM, Nakane PK. Immunoperoxidase technics in diagnostic pathology: Report of a workshop sponsored by the National Cancer Institute. Am. J. Clin. Pathol. 1979; 71: 483-488.
69. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29: 577-580.
70. Seto M, Yamamoto K, Iida S et al. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14) (q13:q32) translocation. Oncogene 1992; 7: 1401-1406.
71. Brousset P, Butet V, Chittal S, Selves J, Delsol G. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Lab. Invest. 1992; 67: 457-464.
72. Henle W, Henle G. The immunological approach to study of possible virus-induced human malignancies using the EpsteinBarr virus as example. Prog. Exp. Tumor Res. 1978; 21: 19-48.
73. Harrison DFN. Midline destructive granuloma: Fact or fiction. Laryngoscope 1987; 97: 1049-1053.
74. Ossenkoppele GJ, Mol JJ, Snow GB et al. Radiotherapy versus radiotherapy plus chemotherapy in stages I and II non-Hodgkin's lymphoma of the upper digestive and respiratory tract. Cancer 1987; 60: 1505-1509.
75. Smalley SR, Cupps RE, Anderson JA et al. Polymorphic reticulosis limited to the upper aerodigestive tract: Natural history and radiotherapeutic considerations. Int. J. Radiat. Oncol. Biol. Phys. 1988; 15: 599-605.
76. Andrassy K, Rasmussen N. Treatment of granulomatous disorders of the nose and paranasal sinuses. Rhinology 1989; 27: 221-230.
77. Longo DL, Glasten E, Duffey PL et al. Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. J. Clin. Oncol. 1989; 7: 1295-1302.
78. Itami J, Itami M, Mikata S et al. Non-Hodgkin's lymphoma confined to the nasal cavity: Its relationship to the polymorphic reticulosis and results of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1991; 20: 797-802.
79. Liang R, Todd D, Chang TK et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J. Clin. Oncol. 1995; 13: 666-670.
80. Aozasa K, Watanabe Y, Ikeda H. Malignant histiocytosis presenting as lethal midline granuloma. Pathol. Res. Pract. 1981; 171: 314-324.
81. Jaffe ES, Costa J, Fauci AS et al. Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am. J. Med. 1983; 75: 741-749.
82. Chen RL, Su IJ, Lin HK et al. Fulminant childhood hemophagocytosis syndrome mimicking histiocytic medullary reticulosis: An atypical form of Epstein-Barr virus infection. Am. J. Clin. Pathol. 1991; 96: 171-176.
83. Cheng AL, Su IJ, Chen YC, Uen WC, Wang CH. Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma. Cancer 1993; 72: 909-916.
84. Su IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM. Epstein-Barr virus containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 1993; 72: 2019-2027.
85. Kikuta T, Sakiyama Y, Matsumoto S et al. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood 1993; 82: 3259-3264.
86. Fukayama M, Ibuka T, Hayashi Y, Ooba T, Koike M, Mizutani S. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am. J. Pathol. 1993; 143: 1044-1049.
87. Sasajima Y, Yamabe H, Kobashi Y, Hirai K, Mori S. High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas. Am. J. Pathol. 1993; 143: 1280-1285.
88. Guinee DJ, Jaffe E, Kingma D et al. Pulmonary lymphomatoid granulomatosis: Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am. J. Surg. Pathol. 1994; 18: 753-764.
89. Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells, Immunol. Today 1992; 13: 392-395.
90. Lanier LL, Chang C, Spits H, Phillips JH. Expression of cytoplasmic CD3 epsilon proteins in activated human adult natural killer (NK) cells and CD3 gamma, delta, epsilon complexes in fetal NK cells. J. Immunol. 1992; 149: 1876-1880.
91. Zocchi MR. Human gamma/delta T lymphocytes use N-CAM to interact with the subendothelial matrix. J. Natl Cancer Inst. 1995; 87: 846-847.
92. Wong KF, Chan JKC, Ng CS, Lee KC, Tsang WYW, Cheung MMC. CD56 (NKH1)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum. Pathol. 1992; 23: 798-804.
93. Tsang WYW, Chan JKC, Yip TTC et al. In-situ localization of Epstein-Barr virus RNA (EBER) in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Hum. Pathol. 1994; 25: 758-765.
94. Ichinohasama R, Endoh K, Ishizawa K et al. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin. Cancer 1996; 77: 2592-2603.
95. Koita H, Suzumiya J, Ohshima K et al. Lymphoblasticlymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity: A case report. Am. J. Surg. Pathol. 1996 (in press).
96. Nichols GE, Normansell DE, Williams ME. Lymphoproliferative disorder of granular lymphocytes: Nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma. Mod. Pathol. 1994; 7: 819-824.
97. Martin AR, Chan WC, Perry DA, Greiner TC. Weisenberger DD. Aggressive natural killer cell lymphoma of the small intestine. Mod. Pathol. 1995; 8: 467-472.